The immunopathogenesis of psoriatic disease
Perekhrestenko, A.P.
Likars'ka Sprava 5: 10-14
2000
ISSN/ISBN: 1019-5297 PMID: 11031438 Document Number: 524517
Document emailed within 1 workday
Related Documents
Nikulin, N.K.; Shutov, A.N. 1984: Function of enzyme systems and circulating immunocytes and their significance in the immunopathogenesis of psoriatic arthritis Vestnik Dermatologii i Venerologii 2: 7-12Lehner, T. 1999: Immunopathogenesis of Behçet's disease Annales de Medecine Interne 150(6): 483-487
Pécsi, G. 2000: Genetic associations and immunopathogenesis of coeliac disease Acta Physiologica Hungarica 87(4): 339-353
Zajkowska, J.M.; Hermanowska-Szpakowicz, T.; Pancewicz, S.A.; Kondrusik, M. 2000: Selected aspects of immunopathogenesis in Lyme disease Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 9(50): 579-583
Debets, R.; Hegmans, J.P.; Croughs, P.; Troost, R.J.; Prins, J.B.; Benner, R.; Prens, E.P. 1997: The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis Journal of Immunology 158(6): 2955-2963
Theiss, B. 1971: Are there typical skin manifestations in psoriatic arthritis and psoriatic spondylarthritis? Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 22(2): 63-68
Salvarani, C.; Lo Scocco, G.; Macchioni, P.; Cremonesi, T.; Rossi, F.; Mantovani, W.; Battistel, B.; Bisighini, G.; Portioli, I. 1995: Prevalence of psoriatic arthritis in Italian psoriatic patients Journal of Rheumatology 22(8): 1499-1503
Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Gladman, D.D.; Rahman, P.; Krueger, G.G.; Mease, P.J.; Qureshi, A.A.; Dutz, J.P.; Lindqvist, U.; Carneiro, S.; Helliwell, P.S.; Ujfalussy, I.; Gottlieb, A.B.; Behrens, F.; Ståhle, M. 2008: Clinical and genetic registries in psoriatic disease Journal of Rheumatology 35(7): 1458-1463
De Vlam, K.; Gottlieb, A.B.; Fitzgerald, O. 2008: Biological biomarkers in psoriatic disease. a review Journal of Rheumatology 35(7): 1443-1448
Cassell, S.; Kavanaugh, A.F. 2006: Therapies for psoriatic nail disease. A systematic review Journal of Rheumatology 33(7): 1452-1456
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942
Goh, C.L.; Khoo, L. 2004: Laser Doppler perfusion imaging (LDPI) and transepidermal water loss (TEWL) values in psoriatic lesions treated with narrow band UVB phototherapy. Dermal vascularity may be useful indicator of psoriatic activity Annals of the Academy of Medicine Singapore 33(1): 75-79
Kousa, M.; Tilikainen, A.; Karvonen, J.; Lassus, A. 1976: Psoriatic arthritis and Reiter's disease. HLA antigens in mixed cases Annals of Clinical Research 8(5): 312-316
Alenius, G-Marie.; Friberg, C.; Nilsson, S.; Wahlström, J.; Dahlqvist, S.Rantapää.; Samuelsson, L. 2004: Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis Journal of Rheumatology 31(11): 2230-2235
Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756
Parrish, C.A.; Sobera, J.O.; Robbins, C.M.; Cantrell, W.C.; Desmond, R.A.; Elewski, B.E. 2006: Alefacept in the treatment of psoriatic nail disease: a proof of concept study Journal of Drugs in Dermatology: Jdd 5(4): 339-340
Forouzandeh, M.; Vazquez, T.; Nouri, K.; Forouzandeh, B. 2019: The Paradoxical Induction of Crohn's Disease Following Treatment of Psoriatic Arthritis with Etanercept Journal of Drugs in Dermatology: Jdd 18(8): 832-834
Papagoras, C.; Voulgari, P.V.; Drosos, A.A. 2013: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis Clinical and Experimental Rheumatology 31(4): 612-620
Bakirci, S.; Solmaz, D.; Al Osaimi, N.; Dalkilic, E.; Can, M.; Erden, A.; Ozisler, C.; Cinar, M.; Kilic, L.; Küçük, A.; Omma, A.; Yildiz, F.; Doğru, A.; Tufan, A.; Esmen, S.E.; Akar, S.; Kalyoncu, U.; Aydin, S.Z. 2019: What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life? Clinical and Experimental Rheumatology 37(5): 808-812